We recently had the privilege of conducting an insightful interview with Dr Kirsi-Marja Oksman-Caldentey, a seasoned professional with over 24 years of experience in the research field. Currently serving as the Senior Advisor at VTT Technical Research Centre of Finland, Dr Oksman-Caldentey sheds light on her extensive journey, from her early years in pharmaceutical biology to her impactful role in coordinating the Inncocells project.
Background and Expertise
Dr Oksman-Caldentey’s journey began with a degree in pharmacy and a Ph.D. in pharmaceutical biology, where her research focused on plant biotechnology, specifically developing plant cell cultures to produce pharmaceutical compounds. She then ventured into the pharmaceutical industry in Switzerland, contributing to groundbreaking research in molecule discovery. Returning to Finland, she continued her career at the University of Helsinki, delving into teaching and research.
In 1999, she joined VTT, a research organization with a dual focus on basic and applied research. Dr Oksman-Caldentey emphasized the critical role of VTT in addressing customer challenges through confidential, direct customer work. She highlighted the importance of jointly funded projects, where VTT collaborates with partners on more basic science-related endeavors. With less than 30% of funding coming directly from the government, VTT strategically allocates resources to drive innovation and open new avenues.
Biobased Solutions and Sustainability
Discussing biobased substances, Dr Oksman-Caldentey acknowledged the immense opportunities they present for sustainable practices across various industries. From medicinal plants to microbes and fungi, researchers are exploring diverse organisms to produce valuable compounds. However, challenges, such as cost and scalability, still hinder widespread adoption. Dr Oksman-Caldentey emphasized the need for education to dispel misconceptions and the importance of showcasing successful examples.
Consumer Acceptance and Circular Economy
When it comes to circular economy adoption and consumer acceptance, Dr Oksman-Caldentey stressed the significance of successful examples. Showcasing companies which produce egg white alternatives sustainably, provides tangible proof of concept. She acknowledged the consumer’s perspective and the need to demonstrate that alternative products are not only safe but also environmentally friendly.
Impact on Legislation and Global Initiatives
Dr Oksman-Caldentey highlighted the role of initiatives like the SECRETEd project in influencing legislation and promoting circular economy practices. She stressed the importance of effective communication and dissemination to showcase achievements and progress. By demonstrating the impact of these projects, they contribute to shaping laws that support environmental protection and sustainable economic growth.
Future of Chemicals from Marine Sources
Discussing the future of chemicals derived from marine sources, Dr Oksman-Caldentey expressed optimism about the vast potential in pharmaceuticals and other industries. Exploring marine biodiversity offers a treasure trove of undiscovered molecules with diverse applications. The cosmetic industry, in particular, is seeking alternatives to chemical preservatives, driving the search for sustainable solutions.
In conclusion, Dr Oksman-Caldentey’s insights shed light on the transformative potential of biobased solutions, the importance of successful examples, and the pivotal role of initiatives like SECRETEd in shaping a sustainable future. Her wealth of experience and dedication to advancing biotechnological innovations make her a trailblazer in the field, driving positive change for both industries and the environment.
